Composite microRNA-genetic risk score model links to migraine and implicates its pathogenesis

Shih-Pin Chen1,2,3,4,5, Ya-Hsuan Chang6, Yen-Feng Wang1,4,5

  • 1Division of Translational Research, Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan.

PubMed

Insights

Researchers developed a novel composite model combining microRNAs (miRNAs) and genetic risk scores to identify migraine patients. This tool shows promise for predicting migraine risk and understanding disease mechanisms.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Migraine's neurobiological mechanisms, including ictal-interictal fluctuations and chronification, are not fully understood.
  • Existing models do not adequately capture the dynamic disease course of migraine.

Purpose of the Study:

  • To construct a composite genetic-microRNA (miRNA) model to reflect dynamic migraine perturbations.
  • To inform the pathogenesis of migraine and differentiate patients from controls.

Main Methods:

  • Prospective recruitment of episodic migraine (interictal and ictal), chronic migraine patients, and controls.
  • Next-generation sequencing for miRNA profiling and genotyping using Axiom Genome-Wide Array TWB chip.
  • Validation of candidate miRNAs using quantitative PCR and exploration of biological pathways.

Main Results:

  • Identified disease-state miRNA signatures (e.g., miR-183, miR-25, miR-320) differentially expressed in migraine patients versus controls.
  • Validated disease-activity miRNA signatures (e.g., miR-1307-5p, let-7e) specifically during the ictal stage of episodic migraine.
  • Developed a composite miRNA-genetic risk score model that differentiated migraine patients from controls with >90% positive predictive value.

Conclusions:

  • A composite miRNA-genetic risk score model was developed as a potential predictive tool for identifying individuals at high risk for migraine.
  • Findings may elucidate pathogenic mechanisms in migraine's dysfunctional allostasis.
  • The model paves the way for future precision medicine approaches in migraine management.